Page Comparison

J1

Competitive acquisition program no-pay submission for a prescription number

J2

Competitive acquisition program, restocking of emergency drugs after emergency administration

J3

Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology

J4

Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge

JA

Administered intravenously

JB

Administered subcutaneously

JC

Skin substitute used as a graft

JD

Skin substitute not used as a graft

JE

Administered via dialysate

JF

Compounded drug

JW

Drug amount discarded/not administered to any patient